Associations of Age and Gender With Negative Symptoms in Schizophrenia
Because the dopaminergic system is sexually dimorphic, researchers found that the same treatment compounds manifest differently for men and women with schizophrenia.
All articles by Cindy Lampner, MSLIS
Efficacy, Safety of Long-Term Ketamine Administration Still In Question
Ketamine, originally approved by the FDA in 1970 as an anesthetic, is increasingly being recognized as an option in treatment-resistant depression.
The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
The guideline formulated by the Centers for Disease Control and Prevention in an effort to curb opioid overdose-related deaths included a recommendation for steep reductions in opioid doses for patients taking high doses of the drug for chronic pain.
Perinatal Mood and Anxiety Screening: Recommendations and Controversies
Although the American College of Obstetricians and Gynecologists and the US Preventive Services Task Force recommend screening for depression in the general adult population, including pregnant and postpartum women, evidence for such screening in the perinatal setting is limited.
Lancet Commission to Tackle Health Inequalities in Mental Illness
The Lancet Commission, “Improving Physical Health Outcomes in People With Mental Illness, will launch in August 2019 with a goal summarizing recent advances, identifying high-priority areas, and presenting updated recommendations regarding physical health inequalities in patients with mental illness.
Exclusion Criteria for Bipolar Trials Cast Doubt on Generalizability
Eligibility criteria employed in clinical trials assessing pharmacologic treatment of bipolar disorder typically preclude many affected patients, casting doubt about the generalizability of their results.
Light Therapy Effective for Older Adults with Nonseasonal Depression
Rapid onset of antidepressant effects, mild and infrequent adverse effects, and cost-effectiveness position light therapy as an alternative to pharmacologic treatments for depression.
Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
Despite concerns that the digital revolution in psychiatry might lessen the importance of interpersonal relationships between patient and clinician, digital apps have the potential to make the therapeutic alliance even more powerful.
Functional Restoration for Chronic Pain and Depression in the Elderly: Pharmacotherapy and Beyond
Functional restoration is a multimodal approach to chronic pain and depression, and includes psychoeducation about pain, biofeedback, mindfulness training, physical and occupational therapy, and detoxification of narcotics.
Addressing Depression in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome
Clinicians address issues relating to treating patients with comorbid chronic fatigue syndrome and mood disorders.
Next post in Depression Advisor
